Hims & Hers shares fall

His health and that of him (HIM) stocks fall after the US Food and Drug Administration (FDA) announced that the shortage at Eli Lilly (LLY) the weight loss drug, Zepbound, has been resolved. The stock falls on expectations of falling demand as supply of GLP-1 weight-loss drugs improves.

Julie Hyman And Josh Lipton look at how stocks are moving and what investors need to know about the GLP-1 market developments.

For more news and expert analysis on the latest market stocks, visit Market Dominance. here.

This article was written by Naomi Buchanan.